CannabIP: U.S. Patent No. 9,943,491 B2
U.S. Patent No. 9,943,491 B2 issued on April 17, 2018, for “Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety...
Category: "cannabip"
CannabIP: U.S. Patent No. 9,962,340 B2
U.S. Patent No. 9,962,340 B2 issued on May 8, 2018, for “Device and method for the transdermal delivery of cannabidiol.” It was issued to applicant Medipatch Inc., of San Diego, California, and...
CannabIP: U.S. Patent No. 9,938,663 B2
U.S. Patent No. 9,938,663 B2 issued on April 10, 2018, for “Methods for Producing Raw Materials from Plant Biomass,” to applicant 9Fiber, Inc., of Silver Spring, Maryland, and inventor Adam Powars,...
CannabIP: U.S. Patent No. 9,937,147 B2
U.S. Patent No. 9,937,147 B2 issued on April 10, 2018, for “Edible Base Product Composition,” to applicant NBDD, Inc., and inventor Doug DeGeeter, of San Francisco, California. The claims are...
CannabIP: FDA Approves First Drug with CBD Active Ingredient
On June 25, 2018, the Food & Drug Administration (FDA) issued a press release in which it approved EPIDIOLEX® for treatment of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome. Lennox-Gastaut...
CannabIP: U.S. Patent No. 9,901,607 B2
U.S. Patent No. 9,901,607 B2 issued on February 27, 2018, to Mark J. Silen, directed to compositions and method of manufacture of preparing and manufacturing smokeless controlled release of...
CannabIP: U.S. Patent No. 9,894,936 B2
U.S. Patent No. 9,894,936 B2 issued on February 20, 2018, for “Zoned Vaporizer,” to Mark Krietzman. The claims are directed to vape apparatuses, one a full system and the other a portable device....
CannabIP: U.S. Patent No. 9,889,100 B2
U.S. Patent No. 9,889,100 B2 issued on February 13, 2018, for “Cannabidiol for Treatment of Severe and Refractory Graft-Versus-Host Disease.” The inventor is Moshe Yeshurun, and the...
CannabIP: U.S. Patent No. 9,895,342 B2
U.S. Patent No. 9,895,342 B2 issued on February 20, 2018, for “Cannabinoids for Use in the Treatment of Neuropathic Pain.” It is assigned to GW Pharma Ltd., which is a fairly large pharmaceutical...
CannabIP: U.S. Patent No. 9,895,404 B1
U.S. Patent No. 9,895,404 B1 issued on February 20, 2018, for “Cannabidiol Extraction Plant and Processes,” to Paul T. Baskis. Source: U.S. Patent No. 9,895,404 B1, “Cannabidiol Extraction Plant and...
Select Category
All Categories
101 102 103 112 11th amendment 13th amendment 1st amendment 256 5th amendment aia anticipation appeals aqua products article ii article iii artificial intelligence assignment assignor estoppel doctrine authorship bri cancellation cannabip captive audience doctrine cbm ccb cip circuit watch collateral estoppel commercial success constitution copying copyright corporate law covid damages copyright derivation descriptiveness design dilution disclaimer distinctiveness divisional dmca double patenting droit de suite duty of disclosure enablement estoppel ethics ex parte proceeding failure-to-function fair use false endorsement false suggestion fed circuit watch fees first sale doctrine foreign equivalents functionality generic geographical indication indefiniteness inequitable conduct infringement copyright infringement trademark interference inventorship ip practicum ipr judicial review jurisdiction lexicography licensing likelihood of confusion motivation to combine nil nominative fair use obviousness on sale bar originality overlapping ranges ownership patent patent agent patent agent privilege patent eligible subject matter patent exhaustion doctrine patent licensing patent litigation pct pgr phillips standard plant plantip posita pre aia prior art priority privacy process prosecution history estoppel pta ptab pte public use pvp real party in interest reasonable expectation of success reduction to practice registration reissue res judicata restriction right of publicity right-to-repair routine practice rule 12b6 sas scams scotus watch section 2a section 2c section 2d section 2e section 2f section 43a selection and arragement sovereign immunity standard of review standing substantial similarity substantial similarity infringement copyright swearing behind technology techpat term terminal disclaimer termination thin-copyright-protection trade secrets trademark transformative use trials ttab uncategorized unclean hands unlawful appropriation useful articles utility venue wine spirts work-for-hire written description wurc zone of interests
Explore Popular Tags
trademarks
(25)
patents
(14)
copyrights
(14)
trademarkregistration
(9)
IPtech
(8)
ai
(7)
copyright
(6)
artificial intelligence
(6)
software
(4)
substantial similarity
(4)
infringement
(3)
distinctiveness
(3)
generic
(3)
authorship
(3)
copyright registration
(3)
likelihoodofconfusion
(3)
nil
(3)
fair use
(3)
ip
(3)
intellectual property
(3)